Chad Walding, DPT, NativePath's co-founder - which addresses the clinical mechanisms behind structural collagen loss during weight loss in a more substantive way than most collagen brands attempt
FDA Approval: The FDA branded medications containing semaglutide and tirzepatide are approved for chronic weight management, while compounded formulations are not FDA-approved for this specific use
So in an insulin-resistant person who is eating less but still triggering high insulin, the body may burn through muscle while protecting fat stores
Some patients may stay on GLP-1 therapy long-term, while others transition off with continued support
Large clinical trials have not identified increased fracture risk with these treatments
Trials in this area are often small, use different doses, and measure different things